Swiss National Bank Geron Corp Transaction History

Swiss National Bank

$137 Billion
Q1 2025

A detailed history of Swiss National Bank transactions in Geron Corp stock. As of the latest transaction made, Swiss National Bank holds 995,500 shares of GERN stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

995,500

Previous 1,007,800 1.22%

Holding current value

$1.33 Million

Previous $3.57 Million 55.65%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$1.59 - $3.6 $19,557 - $44,280	-12,300 Reduced 1.22%	995,500 $1.58 Million
Q4 2024 Feb 10, 2025	BUY	$3.3 - $4.44 $450,120 - $605,616	136,400 Added 15.65%	1,007,800 $3.57 Million
Q3 2024 Nov 07, 2024	BUY	$4.17 - $4.99 $252,702 - $302,394	60,600 Added 7.47%	871,400 $3.96 Million
Q2 2024 Aug 08, 2024	BUY	$3.1 - $5.09 $20,150 - $33,085	6,500 Added 0.81%	810,800 $3.44 Million
Q1 2024 May 07, 2024	BUY	$1.75 - $3.44 $53,725 - $105,608	30,700 Added 3.97%	804,300 $2.65 Million
Q4 2023 Feb 06, 2024	SELL	$1.74 - $2.31 $405,246 - $537,999	-232,900 Reduced 23.14%	773,600 $1.63 Million
Q3 2023 Nov 08, 2023	BUY	$2.11 - $3.28 $20,467 - $31,815	9,700 Added 0.97%	1,006,500 $2.13 Million
Q2 2023 Aug 09, 2023	BUY	$1.97 - $3.69 $383,953 - $719,181	194,900 Added 24.3%	996,800 $3.2 Million
Q1 2023 May 10, 2023	SELL	$2.14 - $3.4 $40,874 - $64,940	-19,100 Reduced 2.33%	801,900 $1.74 Million
Q4 2022 Feb 08, 2023	BUY	$2.03 - $2.42 $45,268 - $53,966	22,300 Added 2.79%	821,000 $1.99 Million
Q2 2022 Aug 09, 2022	BUY	$1.19 - $1.65 $270,963 - $375,705	227,700 Added 39.88%	798,700 $1.24 Million
Q1 2022 May 09, 2022	BUY	$0.99 - $1.6 $43,956 - $71,040	44,400 Added 8.43%	571,000 $777,000
Q2 2021 Aug 06, 2021	SELL	$1.25 - $1.83 $221,000 - $323,544	-176,800 Reduced 25.14%	526,600 $743,000
Q3 2020 Nov 09, 2020	BUY	$1.59 - $2.19 $29,415 - $40,515	18,500 Added 2.7%	703,400 $1.22 Million
Q2 2020 Aug 05, 2020	BUY	$1.05 - $2.18 $312,270 - $648,332	297,400 Added 76.75%	684,900 $1.49 Million
Q1 2020 May 08, 2020	BUY	$0.89 - $1.49 $23,763 - $39,783	26,700 Added 7.4%	387,500 $461,000
Q4 2019 Feb 06, 2020	BUY	$1.27 - $1.54 $26,924 - $32,648	21,200 Added 6.24%	360,800 $491,000
Q1 2019 May 10, 2019	BUY	$1.01 - $1.83 $15,049 - $27,267	14,900 Added 4.59%	339,600 $564,000
Q4 2018 Feb 13, 2019	BUY	$0.98 - $1.85 $22,344 - $42,180	22,800 Added 7.55%	324,700 $325,000
Q3 2018 Nov 08, 2018	BUY	$1.76 - $6.38 $30,800 - $111,650	17,500 Added 6.15%	301,900 $531,000
Q1 2018 May 04, 2018	BUY	$1.81 - $5.98 $59,549 - $196,742	32,900 Added 13.08%	284,400 $1.21 Million
Q3 2017 Nov 03, 2017	BUY	$1.99 - $2.65 $500,485 - $666,475	251,500	251,500 $548,000

Others Institutions Holding GERN

# of Institutions

295

Shares Held

496M

Call Options Held

799K

Put Options Held

463K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $506M
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Geron Corp Transaction History